BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31105270)

  • 21. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
    Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma.
    Hattori S; Miyajima A; Hirasawa Y; Kikuchi E; Kurihara I; Miyashita K; Shibata H; Nakagawa K; Oya M
    J Endourol; 2014 Jun; 28(6):686-92. PubMed ID: 24499341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
    Gupta S; Zhang J; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Therapies in Pheochromocytoma and Paraganglioma.
    Wang K; Crona J; Beuschlein F; Grossman AB; Pacak K; Nölting S
    J Clin Endocrinol Metab; 2022 Nov; 107(11):2963-2972. PubMed ID: 35973976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
    Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
    Tanabe A; Naruse M; Nomura K; Tsuiki M; Tsumagari A; Ichihara A
    Horm Cancer; 2013 Apr; 4(2):103-10. PubMed ID: 23361939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
    Asai S; Katabami T; Tsuiki M; Tanaka Y; Naruse M
    Horm Cancer; 2017 Apr; 8(2):108-118. PubMed ID: 28108930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
    Ferrara AM; Lombardi G; Pambuku A; Meringolo D; Bertorelle R; Nardin M; Schiavi F; Iacobone M; Opocher G; Zagonel V; Zovato S
    Anticancer Drugs; 2018 Jan; 29(1):102-105. PubMed ID: 29099418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
    Huang H; Abraham J; Hung E; Averbuch S; Merino M; Steinberg SM; Pacak K; Fojo T
    Cancer; 2008 Oct; 113(8):2020-8. PubMed ID: 18780317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
    Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
    Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
    Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
    J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic therapies for pheochromocytoma and paraganglioma.
    Jimenez C; Fazeli S; Román-Gonzalez A
    Endocr Relat Cancer; 2020 Jul; 27(7):R239-R254. PubMed ID: 32369773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
    Kukla U; Łabuzek K; Chronowska J; Bobrzyk M; Madej P; Okopień B
    Pol Merkur Lekarski; 2015 Apr; 38(226):191-5. PubMed ID: 25938384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic status determines
    Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma/paraganglioma.
    Lee SE; Oh E; Lee B; Kim YJ; Oh DY; Jung K; Choi JS; Kim J; Kim SJ; Yang JW; An J; Oh YL; Choi YL
    Oncotarget; 2016 Apr; 7(17):24141-53. PubMed ID: 27007161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients with Metastatic Pheochromocytomas/Paragangliomas.
    Zhou Y; Cui Y; Zhang D; Tong A
    J Clin Endocrinol Metab; 2023 Feb; 108(3):755-766. PubMed ID: 36383456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pheochromocytomas and paragangliomas in humans and dogs.
    Galac S; Korpershoek E
    Vet Comp Oncol; 2017 Dec; 15(4):1158-1170. PubMed ID: 28120550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.